| CPC A61K 9/0056 (2013.01) [A23L 5/30 (2016.08); A23L 27/36 (2016.08); A23L 33/155 (2016.08); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2095 (2013.01)] | 5 Claims |
|
1. A buccal micro-effervescent tablet comprising:
a nutrient, wherein the nutrient is Vitamin C;
a sugar alcohol, wherein the sugar alcohol is a combination of lactose and maltitol and wherein the ratio of lactose to maltitol is 1:2.2-1:4.5 in parts by weight;
an acid source, wherein the acid source is citric acid, tartaric acid, fumaric acid, malic acid, or any combination thereof;
an alkali source, wherein the alkali source is sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate or any combination thereof;
a magnesium stearate;
an essence; and
a sweetening agent, wherein the sweetening agent is a combination of sucralose, aspartame and stevioside,
wherein the buccal micro-effervescent tablet comprises in parts by weight: 8-12 parts of the nutrient, 10-80 parts of the sugar alcohol, 11-19 parts of the acid source, 11-18 parts of the alkali source, 0.1-3 parts of the magnesium stearate, 1-5 parts of the essence and 0.1-3 parts of the sweetening agent.
|